Crohn's Allogeneic Transplant Study

NCT01570348 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Annual accrual goal not met

Conditions

Crohn Disease

Interventions

PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
OTHER: Laboratory Biomarker Analysis
DRUG: Mycophenolate Mofetil
DRUG: Mycophenolic Acid
OTHER: Quality-of-Life Assessment
DRUG: Tacrolimus
RADIATION: Total-Body Irradiation

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]